Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Oct;167(10):668-72.
doi: 10.1016/j.neurol.2011.07.002. Epub 2011 Aug 31.

Immunotherapy in Human Glioblastoma


Immunotherapy in Human Glioblastoma

A T Szabo et al. Rev Neurol (Paris). .


Glioblastoma patients spontaneously develop anti-tumour immune responses. However, the tumour itself develops several mechanisms that allow the tumor to escape the immune system. Clinical trials using infusion of activated autologous immune cells, or active immunotherapy with tumor antigens and dendritic cells have successfully induced anti-tumour immunity and some radiological responses. More recently, approaches targeting the mechanisms of tolerance have shown promising data in melanoma, and are currently under investigations in gliomas. However, large randomised trials are still needed to prove the usefulness of cancer vaccines in brain tumors.

Similar articles

See all similar articles

Cited by 4 articles